費用・規模
- 経費率
- 0.4000%
- ベンダー値
- ベンダー記録日 2026-03-18
- 純資産総額
- $715.68M
- ベンダー値
- ベンダー記録日 2026-03-18
- 取得済み明細
- 50件
- 総数は未確認
- ベンダー記録日 2026-03-18
- 上位10銘柄の比率
- 21.45%
- 取得済み上位10件の合計
- ベンダー記録日 2026-03-18
$ 38.8
-
相対評価は未実施(比較対象・重みが未確定)
The Invesco S&P 500 Equal Weight Health Care ETF aims to track the performance of the S&P 500 Equal Weight Health Care Index. This fund primarily allocates a minimum of 90% of its total assets to the common stocks that constitute its underlying benchmark. The Index itself assigns an equal weighting to all healthcare sector companies that are part of the broader S&P 500 Index. Both the ETF and the Index undergo a portfolio adjustment process on a quarterly basis.
| Ticker | Company | Weight |
|---|---|---|
| MRNA | Moderna Inc | 3.13% |
| DVA | DaVita HealthCare Partners I… | 2.20% |
| GILD | Gilead Sciences Inc | 2.07% |
| MRK | Merck & Company Inc | 2.05% |
| JNJ | Johnson & Johnson | 2.02% |
| VTRS | Viatris Inc | 2.01% |
| AMGN | Amgen Inc | 2.01% |
| MCK | McKesson Corporation | 2.00% |
| BMY | Bristol-Myers Squibb Company | 2.00% |
| HCA | HCA Holdings Inc | 1.97% |
| 銘柄 | 株価 | 配当利回り |
|---|